THALASSEMIA: THE HEREDITARY RECESSIVE DISEASE IN SILENT CARRIERS: NEW VIEWPOINTS IN SCREENING TEST

Duc Tam Lam1, , Thanh Dien Doan1, Thi Gai Le1, Thi Thuy Hang Ngo1, Quynh Trang Truong1, Dac Loc Pham1
1 Can Tho university of Medicine and Pharmacy

Main Article Content

Abstract

The thalassemias are a group of hereditary hemolytic anemia disease that result from inherited defects in the synthesis of globin. There are two main forms – alpha thalassemia and beta thalassemia, each with various subtypes; which 7 % of worldwide population carry hemolytic genes, from 60.000 – 70.000 newborns confronted with severe Beta Thalassemia. Thalassemia is an autosomal recessive hereditary, which means the relevance in two genders is equivalent. If both husbands and wives are carriers, one fourth of their descendants are affected, half are heterozygotes, and one fourth are normal. Thalassemia patients require red blood cell transfusion, with or without iron chelation therapy throughout their life, creating burdens to their physical and mental health, negative effects to quality of life. And invisibly, exposes them to be an economic burden for family and society when they suffer huge treatment costs. The establishment of diagnosis is usually late with anemia as a clinical symptom, and through blood test, hemoglobin electrophoresis. However, due to the development of biotechnology science, prenatal diagnosis to carrier screening based on autosomal recessive shows the promise in Thalassemia diagnosis and treatment.

Article Details

References

1. Ngô Trường Giang (2016), Nghiên cứu xây dựng quy trình phát hiện đột biến gen gây bệnh - thalassemia trước chuyển phôi bằng phương pháp minisequencing, Luận văn thạc sĩ Y học, Trường Đại học Y Hà Nội.
2. Nguyễn Đình Tảo, Trần Văn Khoa và Quản Hoàng Lâm (2018), Nghiên cứu xây dựng quy trình chẩn đoán một số bệnh di truyền trước chuyển phôi để sàng lọc phôi thụ tinh trong ống nghiệm, Đề tài cấp nhà nước, Học viện Quân y.
3. Dang Tien Truong, Ngo Van Nhat Minh, el al. (2019), Short Tandem Repeats Used in
Preimplantation Genetic Testing of Β-Thalassemia: Genetic Polymorphisms For 15 Linked Loci in the Vietnamese Population, Open Access Maced J Med Sci, 7(24), pp. 4383-4388.
4. Aspasia Destouni, George Christopoulos et al, (2012), Microsatellite markers within the αglobin gene cluster for robust preimplantation genetic diagnosis of severe α-thalassemia syndromes in Mediterranean populations, Hemoglobin, 36(3), pp. 253-264.
5. Belinda Giardine, Joseph Borg et al. (2014), Updates of the HbVar database of human hemoglobin variants and thalassemia mutations, Nucleic Acids Res, 42(D1), pp. D1063D1069.
6. Bernadette Modella, Matthew Darlisona (2008), Global epidemiology of haemoglobin disorders and derived service indicators, Bulletin of the World Health Organization, 86, pp. 480 – 487.
7. Christine Yap, AS Tan et al, (2009), First successful preimplantation genetic diagnosis in Singapore–avoidance of beta-thalassaemia major, Ann Acad Med Singapore, 38(8), pp. 720-723.
8. Chen, R. Li et al (2021), Noninvasive prenatal testing of alpha-thalassemia and beta- thalassemia through population-based parental haplotyping, Genome Med, 13(1), pp. 18.
9. ESHRE PGT Consortium Steering Committee, Filipa Carvalho et al. (2020), ESHRE PGT Consortium good practice recommendations for the organisation of PGT, Hum Reprod Open, 2020(3), pp. 021.
10. Fatima Dahmani, Souad Benkirane et al, (2017), Epidemiological profile of hemoglobinopathies: a cross-sectional and descriptive index case study, Pan Afr Med J, 27, pp. 150-150.
11. G. L. Harton, M. De Rycke et al, (2011), ESHRE PGD consortium best practice guidelines for amplification-based PGD, Hum Reprod Open, 26(1), pp. 33-40.
12. Schrijver, S. C. Cherny and J. L. Zehnder (2007), Testing for maternal cell contamination in prenatal samples: a comprehensive survey of current diagnostic practices in 35 molecular diagnostic laboratories, J Mol Diagn, 9(3), pp. 394-400.
13. Kasorn Tiewsiri, Somjate Manipalviratn et al, (2020), The First Asian, Single-Center Experience of Blastocyst Preimplantation Genetic Diagnosis with HLA Matching in Thailand for the Prevention of Thalassemia and Subsequent Curative Hematopoietic Stem Cell Transplantation of Twelve Affected Siblings, BioMed Research International, 2020, pp. 10.
14. Li Fan, Aiping Qin et al (2017), Genetic diagnosis of beta-thalassemia preimplantation using short tandem repeats in human cryopreserved blastocysts, International Journal of Clinical and Experimental Pathology, 10(7), pp. 7586-7595.
15. Martine De Rycke và Veerle J Genes Berckmoes (2020), Preimplantation Genetic Testing for monogenic disorders, Genes (Basel), 2020-11(8), p. 871.
16. R. M. Frederickson, H. S. Wang và L. C. Surh (1999), Some caveats in PCR-based prenatal diagnosis on direct amniotic fluid versus cultured amniocytes, Prenat Diagn. 19(2), pp. 113-7.
17. Sir David J. Weatherall, Williams (2010), The Thalassemias: Disorders of Globin Synthesis, Hematology, 8 edit, Chapter 47.
18. Thalassemia Internation Federation annual report (2013), A global public health paradigm, Thalassemia Reports, 4.